Schedule 13G ownership disclosure

ADURO BIOTECH, INC.

Security class unavailable · CUSIP: 00739L101

Event date: 2019-01-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
0
Percent of class
0.0000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000902219-19-000022
Form type
SC 13G
Filer
CHINOOK THERAPEUTICS, INC.
CIK
CIK 1435049
Filed
Feb 11, 2019
Reporting period
Jan 31, 2019
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub